SEC Filing Update: #OVID Ovid Therapeutics Inc. : $2.88

Sector: Healthcare | YTD: 🔼+ 63.64% The SEC disclosed Today (14-AUG-2026) that RA CAPITAL MANAGEMENT has INCREASED #OVID Shares by 86.17% 🟢 BALYASNY ASSET MANAGEMENT LLC also reported an increase in its holdings on the same day. ADAR1 Capital Management, LLC also reported an increase in its holdings on the same day. * Previous Holdings: 10.50M Shares * Current Holdings: 19.55M Shares * Increase+9.05M * Increased(%)+86.17% * Ownership: 9.9% * Estimated Investment Value: $23.71M https://www.thinksabio.com/reports/isr/OVID Institutional ownership in #OVID has been steadily rising over the past 4 quarters in Shares: Q2 2025: 35.97M Q3 2025: 36.21M Q4 2025: 61.87M Q1 2026: 105.07M The quarterly average prices of #OVID: Q3 2025: $0.87 Q4 2025: $1.54 Q1 2026: $1.79 📌 Institutional activity in the last 30 days for #OVID: • AFFINITY ASSET ADVISORS, LLC – Increased holdings by 4,999,166 shares (13-AUG-2026) • BALYASNY ASSET MANAGEMENT LLC – Increased holdings by 2,284,118 shares (14-AUG-2026) • ADAR1 Capital Management, LLC – Increased holdings by 2,142,500 shares (14-AUG-2026) • BLACKROCK INC – Increased holdings by 9,289,389 shares (29-JUL-2026)